| ■ 영문 제목 : Global Epinephrine Autoinjector Market 2023-2027
|
 | ■ 상품코드 : IRTNTR43297-23
■ 조사/발행회사 : Technavio
■ 발행일 : 2022년 11월
■ 페이지수 : 약120
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (24시간 이내)
■ 조사대상 지역 : 세계
■ 산업 분야 : 의료 기기
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1명 열람용) | USD2,500 ⇒환산￦3,500,000 | 견적의뢰/주문/질문 |
| Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산￦5,600,000 | 견적의뢰/주문/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
테크나비오 조사회사는 세계의 에피네프린 자동 주사기 시장 규모가 2022년부터 2027년까지 연평균 9.68% 성장하여, 2014.33백만 달러에 달할 것으로 예측하고 있습니다. 본 조사 보고서는 세계의 에피네프린 자동 주사기 시장에 대해 다방면으로 조사 및 분석하여, 개요, 시장 현황, 시장 규모, 과거 시장 규모, 파이브 포스 분석, 투여량별 (0.30gm, 0.15gm, 0.50gm) 분석, 최종 용도별 (병원, 클리닉, 재택 의료) 분석, 고객 현황, 지역별 현황 (북미, 유럽, 아시아, 미국, 독일, 영국, 중국, 일본, 기타 지역) 분석, 추진 요인/과제/동향, 기업 현황, 기업 분석 등의 항목을 게재하고 있습니다. 또한 본 자료는 Adamis Pharmaceuticals Corp., ALK Abello AS, Amneal Pharmaceuticals Inc., BIOPROJET, Crossject, Halozyme Therapeutics Inc., Kaleo Inc., Shionogi and Co. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Windgap Medical Inc., Bausch Health Co Inc.와 같은 기업 정보를 포함하고 있습니다.
・개요
・시장 현황
・시장 규모
・과거 시장 규모
・파이브 포스 분석
・세계의 에피네프린 자동 주사기 시장 규모 : 투여량별
- 투여량 0.30gm 에피네프린 자동 주사기의 시장 규모
- 투여량 0.15gm 에피네프린 자동 주사기의 시장 규모
- 투여량 0.50gm 에피네프린 자동 주사기의 시장 규모
・세계의 에피네프린 자동 주사기 시장 규모 : 최종 용도별
- 병원에서 사용되는 에피네프린 자동 주사기의 시장 규모
- 클리닉에서 사용되는 에피네프린 자동 주사기의 시장 규모
- 재택 의료에서 사용되는 에피네프린 자동 주사기의 시장 규모
・고객 현황
・지역별 현황
- 북미의 에피네프린 자동 주사기 시장 규모
- 유럽의 에피네프린 자동 주사기 시장 규모
- 아시아의 에피네프린 자동 주사기 시장 규모
- 미국의 에피네프린 자동 주사기 시장 규모
- 독일의 에피네프린 자동 주사기 시장 규모
- 영국의 에피네프린 자동 주사기 시장 규모
- 중국의 에피네프린 자동 주사기 시장 규모
- 일본의 에피네프린 자동 주사기 시장 규모
- 기타 지역의 에피네프린 자동 주사기 시장 규모
・추진 요인/과제/동향
・기업 현황
・기업 분석
테크나비오사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 테크나비오사의 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다. |
■ 보고서 개요Global Epinephrine Autoinjector Market 2023-2027Technavio has been monitoring the epinephrine autoinjector market and it is poised to grow by $2014.33 mn during 2023-2027, accelerating at a CAGR of 9.68% during the forecast period. Our report on the epinephrine autoinjector market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of allergies, marketing strategies, and rse in awareness of anaphylaxis and the availability of innovative epinephrine autoinjectors.
Technavio’s epinephrine autoinjector market is segmented as below:
By Dosage
• 0.30gm
• 0.15gm
• 0.50gm
By End-user
• Hospitals
• clinics
• Homecare
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the tentative product launches as one of the prime reasons driving the epinephrine autoinjector market growth during the next few years. Also, growing awareness about epinephrine autoinjectors and patient assistance programs will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the epinephrine autoinjector market covers the following areas:
• Epinephrine autoinjector market sizing
• Epinephrine autoinjector market forecast
• Epinephrine autoinjector market industry analysis
Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading epinephrine autoinjector market vendors that include Adamis Pharmaceuticals Corp., ALK Abello AS, Amneal Pharmaceuticals Inc., BIOPROJET, Crossject, Halozyme Therapeutics Inc., kaleo Inc., Shionogi and Co. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Windgap Medical Inc., and Bausch Health Co Inc. Also, the epinephrine autoinjector market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
■ 보고서 목차• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Dosage
o Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global epinephrine autoinjector market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global epinephrine autoinjector market 2017 – 2021 ($ million)
o 4.2 Dosage Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Dosage Segment 2017 – 2021 ($ million)
o 4.3 End-user Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Dosage
o 6.1 Market segments
o Exhibit 30: Chart on Dosage – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Dosage – Market share 2022-2027 (%)
o 6.2 Comparison by Dosage
o Exhibit 32: Chart on Comparison by Dosage
o Exhibit 33: Data Table on Comparison by Dosage
o 6.3 0.30gm – Market size and forecast 2022-2027
o Exhibit 34: Chart on 0.30gm – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on 0.30gm – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on 0.30gm – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on 0.30gm – Year-over-year growth 2022-2027 (%)
o 6.4 0.15gm – Market size and forecast 2022-2027
o Exhibit 38: Chart on 0.15gm – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on 0.15gm – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on 0.15gm – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on 0.15gm – Year-over-year growth 2022-2027 (%)
o 6.5 0.50gm – Market size and forecast 2022-2027
o Exhibit 42: Chart on 0.50gm – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on 0.50gm – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on 0.50gm – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on 0.50gm – Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Dosage
o Exhibit 46: Market opportunity by Dosage ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 47: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 48: Data Table on End-user – Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 49: Chart on Comparison by End-user
o Exhibit 50: Data Table on Comparison by End-user
o 7.3 Hospitals and clinics – Market size and forecast 2022-2027
o Exhibit 51: Chart on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
o 7.4 Homecare – Market size and forecast 2022-2027
o Exhibit 55: Chart on Homecare – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Homecare – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Homecare – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Homecare – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by End-user
o Exhibit 59: Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 65: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 89: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 93: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 101: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 Adamis Pharmaceuticals Corp.
o Exhibit 108: Adamis Pharmaceuticals Corp. – Overview
o Exhibit 109: Adamis Pharmaceuticals Corp. – Business segments
o Exhibit 110: Adamis Pharmaceuticals Corp. – Key offerings
o Exhibit 111: Adamis Pharmaceuticals Corp. – Segment focus
o 12.4 ALK Abello AS
o Exhibit 112: ALK Abello AS – Overview
o Exhibit 113: ALK Abello AS – Product / Service
o Exhibit 114: ALK Abello AS – Key offerings
o 12.5 Amneal Pharmaceuticals Inc.
o Exhibit 115: Amneal Pharmaceuticals Inc. – Overview
o Exhibit 116: Amneal Pharmaceuticals Inc. – Business segments
o Exhibit 117: Amneal Pharmaceuticals Inc. – Key news
o Exhibit 118: Amneal Pharmaceuticals Inc. – Key offerings
o Exhibit 119: Amneal Pharmaceuticals Inc. – Segment focus
o 12.6 Bausch Health Co Inc.
o Exhibit 120: Bausch Health Co Inc. – Overview
o Exhibit 121: Bausch Health Co Inc. – Business segments
o Exhibit 122: Bausch Health Co Inc. – Key news
o Exhibit 123: Bausch Health Co Inc. – Key offerings
o Exhibit 124: Bausch Health Co Inc. – Segment focus
o 12.7 BIOPROJET
o Exhibit 125: BIOPROJET – Overview
o Exhibit 126: BIOPROJET – Product / Service
o Exhibit 127: BIOPROJET – Key offerings
o 12.8 Crossject
o Exhibit 128: Crossject – Overview
o Exhibit 129: Crossject – Product / Service
o Exhibit 130: Crossject – Key offerings
o 12.9 Halozyme Therapeutics Inc.
o Exhibit 131: Halozyme Therapeutics Inc. – Overview
o Exhibit 132: Halozyme Therapeutics Inc. – Product / Service
o Exhibit 133: Halozyme Therapeutics Inc. – Key offerings
o 12.10 kaleo Inc.
o Exhibit 134: kaleo Inc. – Overview
o Exhibit 135: kaleo Inc. – Product / Service
o Exhibit 136: kaleo Inc. – Key offerings
o 12.11 Shionogi and Co. Ltd.
o Exhibit 137: Shionogi and Co. Ltd. – Overview
o Exhibit 138: Shionogi and Co. Ltd. – Product / Service
o Exhibit 139: Shionogi and Co. Ltd. – Key offerings
o 12.12 Teva Pharmaceutical Industries Ltd.
o Exhibit 140: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 141: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 142: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 143: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 144: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.13 Viatris Inc.
o Exhibit 145: Viatris Inc. – Overview
o Exhibit 146: Viatris Inc. – Business segments
o Exhibit 147: Viatris Inc. – Key offerings
o Exhibit 148: Viatris Inc. – Segment focus
o 12.14 Windgap Medical Inc.
o Exhibit 149: Windgap Medical Inc. – Overview
o Exhibit 150: Windgap Medical Inc. – Product / Service
o Exhibit 151: Windgap Medical Inc. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 152: Inclusions checklist
o Exhibit 153: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 154: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 155: Research methodology
o Exhibit 156: Validation techniques employed for market sizing
o Exhibit 157: Information sources
o 13.5 List of abbreviations
o Exhibit 158: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Dosage
Exhibits6: Executive Summary – Chart on Market Segmentation by End-user
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global epinephrine autoinjector market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Dosage Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – End user Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Dosage – Market share 2022-2027 (%)
Exhibits31: Data Table on Dosage – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Dosage
Exhibits33: Data Table on Comparison by Dosage
Exhibits34: Chart on 0.30gm – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on 0.30gm – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on 0.30gm – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on 0.30gm – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on 0.15gm – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on 0.15gm – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on 0.15gm – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on 0.15gm – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on 0.50gm – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on 0.50gm – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on 0.50gm – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on 0.50gm – Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Dosage ($ million)
Exhibits47: Chart on End-user – Market share 2022-2027 (%)
Exhibits48: Data Table on End-user – Market share 2022-2027 (%)
Exhibits49: Chart on Comparison by End-user
Exhibits50: Data Table on Comparison by End-user
Exhibits51: Chart on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Homecare – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Homecare – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Homecare – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Homecare – Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by End-user ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: Adamis Pharmaceuticals Corp. – Overview
Exhibits109: Adamis Pharmaceuticals Corp. – Business segments
Exhibits110: Adamis Pharmaceuticals Corp. – Key offerings
Exhibits111: Adamis Pharmaceuticals Corp. – Segment focus
Exhibits112: ALK Abello AS – Overview
Exhibits113: ALK Abello AS – Product / Service
Exhibits114: ALK Abello AS – Key offerings
Exhibits115: Amneal Pharmaceuticals Inc. – Overview
Exhibits116: Amneal Pharmaceuticals Inc. – Business segments
Exhibits117: Amneal Pharmaceuticals Inc. – Key news
Exhibits118: Amneal Pharmaceuticals Inc. – Key offerings
Exhibits119: Amneal Pharmaceuticals Inc. – Segment focus
Exhibits120: Bausch Health Co Inc. – Overview
Exhibits121: Bausch Health Co Inc. – Business segments
Exhibits122: Bausch Health Co Inc. – Key news
Exhibits123: Bausch Health Co Inc. – Key offerings
Exhibits124: Bausch Health Co Inc. – Segment focus
Exhibits125: BIOPROJET – Overview
Exhibits126: BIOPROJET – Product / Service
Exhibits127: BIOPROJET – Key offerings
Exhibits128: Crossject – Overview
Exhibits129: Crossject – Product / Service
Exhibits130: Crossject – Key offerings
Exhibits131: Halozyme Therapeutics Inc. – Overview
Exhibits132: Halozyme Therapeutics Inc. – Product / Service
Exhibits133: Halozyme Therapeutics Inc. – Key offerings
Exhibits134: kaleo Inc. – Overview
Exhibits135: kaleo Inc. – Product / Service
Exhibits136: kaleo Inc. – Key offerings
Exhibits137: Shionogi and Co. Ltd. – Overview
Exhibits138: Shionogi and Co. Ltd. – Product / Service
Exhibits139: Shionogi and Co. Ltd. – Key offerings
Exhibits140: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits141: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits142: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits143: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits144: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits145: Viatris Inc. – Overview
Exhibits146: Viatris Inc. – Business segments
Exhibits147: Viatris Inc. – Key offerings
Exhibits148: Viatris Inc. – Segment focus
Exhibits149: Windgap Medical Inc. – Overview
Exhibits150: Windgap Medical Inc. – Product / Service
Exhibits151: Windgap Medical Inc. – Key offerings
Exhibits152: Inclusions checklist
Exhibits153: Exclusions checklist
Exhibits154: Currency conversion rates for US$
Exhibits155: Research methodology
Exhibits156: Validation techniques employed for market sizing
Exhibits157: Information sources
Exhibits158: List of abbreviations
|
| ※본 조사보고서 [세계의 에피네프린 자동 주사기 시장 (2023년~2027년)] (코드 : IRTNTR43297-23) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 에피네프린 자동 주사기 시장 (2023년~2027년)] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요! 세계의 에피네프린 자동 주사기 시장 (2023년~2027년)
